is glp 1 safe for kidneys GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity GLP-1 drugs may extend life,

The clinical care of patients who have experienced drug allergies requires enhanced monitoring measures [51]

These results have important implications for the food industry

Where there is limited evidence, physicians are relying on their training and clinical knowledge to guide them

[1] [5] Currently available GLP-1 medications in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist

If you are considering semaglutide versus Ozempic for weight loss or diabetes, its essential to know the differences before discussing them with your healthcare provider